小剂量尿激酶治疗急性脑梗塞的临床研究  

The Clinical Study of Patients with Acute Cerebral Infarction by Using Smalldose Urokinase

作　　者：石青 马伯扬[2] 余尚贞 

机构地区：[1]广东省江门市五邑中医院神经内科,广东江门529000 [2]第一军医大学珠江医院神经内科,广东广州510000

出　　处：《河北医学》2007年第3期300-302,共3页Hebei Medicine

摘　　要：目的:观察低剂量尿激酶治疗发病在5d以内的急性脑梗塞患者的临床效果及评价小剂量溶栓药在使用过程中的安全性.方法:治疗组采用小剂量尿激酶(15万u)静脉滴注,对照组以丹参注射液20ml静脉滴注,共持续10～15d,相互及前后进行神经功能缺损评分.结果:发现治疗组与对照组有显著差异(P＜0.05).结论:小剂量尿激酶治疗脑梗塞有效,为临床治疗急性脑梗塞的较好方法.Objective:To observe the clinical efficacy of the patient with acute cerebral infarction within 5 day treated with small-dose Urokinase,and evaluate the safety during the period of using the agent.Method:After the treated group was dripped intravenously with small-dose of urokinase(150000u) and the contrasted group with Danshen injection for 10 to 15 days,then contrast the defect of the nerve functions before and after the treatment.Result:There was a significant difference between the treated group and the contrasted group(P<0.05).Conclusion:It indicated that small-dose of urokinase was a better approach to treat patients with acute cerebral infarction.

关 键 词：尿激酶 脑梗塞 

分 类 号：R743.3[医药卫生—神经病学与精神病学]